Don't be so blantantly obvious shorty..... you are frothing at the mouth your excessive greed is making you write nonsense without any foundation... but that's typical. Money does that. No cure unfortunately since even if/when you get money you blow it all over again.
Sorry Pal you hitched your horses to the wrong wagon this time.
IMO the launch has been successful and is proceeding strongly ... scripts are still increasing w/w by about 20% every week, Tier 2 achieved well ahead of expectation, massive expansion of Tier 2 and Tier 3 coverage, very positive response by medical community ... the idea that Amarin will run out of money any time soon is simply untrue.
Was just checking the cash flow, and with revenues starting to come in, I think AMRN has plenty of cash to work with. Not saying profitable yat, but as bos97 states, woth a 20% increase almost weekly, AMRN could be in the black sooner than people realize.
I guess you missed the results of the marine and anchor trials and decided to ignore the Jellis study and forgot all about the fib warning on lovaza now.....AMRN could end up $30 and still be undervalued when Reduce It shows heart benefits.......